Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
Holding LYEL?
Track your performance easily
Lyell Immunopharma (LYEL) Ownership Overview
43.81% Insiders
12.43% Mutual Funds
37.79% Other Institutional Investors
5.96% Public Companies and
Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail and individual investors. Approximately 50.22% of the company’s stock is owned by Institutional Investors, 43.81% is owned by Insiders and 5.96% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,998,311 | Institution | 5.08% | 17,547,720 | |
| 11,806,630 | Institution | 4.61% | 15,938,951 | |
| 8,481,298 | Institution | 3.31% | 11,449,752 | |
| 5,921,942 | Institution | 2.31% | 7,994,622 | |
| 1,911,602 | Institution | 0.75% | 2,580,663 | |
| 1,688,772 | Institution | 0.66% | 2,279,842 | |
| 1,517,445 | Institution | 0.59% | 2,048,551 | |
| 1,486,286 | Institution | 0.58% | 2,006,486 | |
| 1,147,315 | Institution | 0.45% | 1,548,875 | |
| 859,663 | Institution | 0.34% | 1,160,545 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,806,630 | Institution | 4.61% | 15,938,951 | |
| 5,921,942 | Institution | 2.31% | 7,994,622 | |
| 1,911,602 | Institution | 0.75% | 2,580,663 | |
| 1,688,772 | Institution | 0.66% | 2,279,842 | |
| 1,517,445 | Institution | 0.59% | 2,048,551 | |
| 1,486,286 | Institution | 0.58% | 2,006,486 | |
| 1,147,315 | Institution | 0.45% | 1,548,875 | |
| 778,764 | Institution | 0.30% | 1,051,331 | |
| 774,894 | Institution | 0.30% | 1,046,107 | |
| 676,627 | Institution | 0.26% | 913,446 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,817,818 | Institution | 2.27% | 9,366,687 | |
| 4,437,748 | Institution | 1.73% | 5,990,960 | |
| 2,520,356 | Institution | 0.98% | 4,057,773 | |
| 2,229,704 | Institution | 0.87% | 3,589,823 | |
| 1,545,739 | Institution | 0.60% | 2,086,748 | |
| 1,258,699 | Institution | 0.49% | 2,026,505 | |
| 873,706 | Institution | 0.34% | 1,179,503 | |
| 779,755 | Institution | 0.30% | 1,083,859 | |
| 630,999 | Institution | 0.25% | 1,015,908 | |
| 420,320 | Institution | 0.16% | 676,715 |
FAQ
Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 37.79% of the company's stock is held by institutional investors, 43.81% is held by insiders, and 5.96% is held by retail investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.79% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.96% of Lyell Immunopharma (LYEL) stock is held by retail investors.
Who owns the most shares of Lyell Immunopharma (LYEL)?
Vanguard owns the most shares of Lyell Immunopharma (LYEL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.